Optimal usage guides for pharmacological treatment of sexually transmitted and blood-borne infections (STBBI)
01-27-2025 | Usage optimal
November 2026 (revision)
INESSS conducted a minor revision of the Optimal Usage Guide - Confirmed Chlamydia trachomatis or Neisseria gonorrhoeae infection and of the Decision algorithm for the epidemiological treatment of asymptomatic partners. This revision follows the update, in October 2026, of the guidance on expedited partner therapy (EPT) for Chlamydia trachomatis and Neisseria gonorrhoeae infections issued by the Institut national de santé publique du Québec (INSPQ). INESSS's information and recommendations regarding EPT have been adjusted accordingly. All other recommendations remain unchanged.
The Institut national d’excellence en santé et en services sociaux (INESSS) has developed a series of optimal usage guides for the pharmacological treatment of sexually transmitted and blood-borne infections (STBBIs). The optimal usage guides are intended for front-line clinicians. They are provided for guidance only and does not replace the judgment of the clinician exercising the activities reserved to him or her by law or regulation. The recommendations included in the optimal usage guides are intended for people aged 14 and over. They have been developed using a systematic approach and are supported by the scientific literature and the knowledge and experience of Quebec clinicians and experts.
The guides address the following conditions:
- confirmed Trichomonas vaginalis infection;
- confirmed Mycoplasma genitalium infection;
- syndromic approach (cervicitis, urethritis, epididymitis/epididymo-orchitis, pelvic inflammatory disease, proctitis);
- genital herpes;
- confirmed Chlamydia trachomatis or Neisseria gonorrhoeae infection;
- syphilis;
- external condylomas.